Abbott Labs’s most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $36.00 short put and a strike $31.00 long put offers a potential 6.16% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $36.00 by expiration. The full premium credit of $0.29 would be kept by the premium seller. The risk of $4.71 would be incurred if the stock dropped below the $31.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 72.51 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Abbott Labs Surges to the Top of the Food Chain
Sat, 19 Oct 2013 21:15:16 GMT
Motley Fool – Nutrition leaders Nestle and Danone have struggled with China’s probe and guidance questions, but Abbott Labs continues to shine.
[$$] Abbott’s 57% Payout Hike
Sat, 19 Oct 2013 04:01:00 GMT
Barrons.com – Abbott Laboratories surprised Wall Street Wednesday with a robust 57% dividend boost. When the global health-care giant (ticker: ABT) split into two companies in January, it reduced its own quarterly common …
Weekly Market Wrap: October 18, 2013
Fri, 18 Oct 2013 19:55:00 GMT
Forbes – This forty-second trading week of 2013 comes to a close with the government shutdown and debt ceiling debate behind us, and the markets higher on speculation that the Fed won’t be tapering in 2013. The Dow Jones Industrial Average, S&P 500 and Nasdaq are all higher for the week. Crude oil futures […]
New Study Demonstrates Importance of Oral Nutritional Supplements in Helping Hospitals Achieve Medicare Readmission Reduction Requirements
Fri, 18 Oct 2013 13:00:00 GMT
PR Newswire – ABBOTT PARK, Ill., Oct. 18, 2013 /PRNewswire/ — (NYSE: ABT) – In the U.S., one in five Medicare patients is readmitted to a hospital each year at an estimated cost of $17.5 billion annually. i To reduce …
Does This Diversified Health Care Giant Have Long-Term Growth Potential?
Thu, 17 Oct 2013 20:18:02 GMT
Motley Fool – Has Abbott Laboratories finally proven that it doesn’t need AbbVie’s high-growth portfolio to keep growing?
Also on Market Tamer…
Follow Us on Facebook